Advertisement
Advertisement
EOLS
Evolus, Inc. Common Stock
7.00
USDSponsored
-0.07
-0.99%
Nov 19, 15:59 UTC -5
Closed
After-Market
6.99
-0.01
-0.14%
Evolus, Inc. Common Stock (EOLS) Earnings
EOLS Earnings Reports
Positive Surprise Ratio
EOLS beat 23 of 36 last estimates.
64%
Next Report
Date of Next Report
Mar 01, 2027
Estimate for Q4 26 (Revenue/ EPS)
$101.12M
/$0.06
Implied change from Q3 26 (Revenue/ EPS)
+29.72%
/-250.00%
Implied change from Q4 25 (Revenue/ EPS)
+13.34%
/+20.00%
Evolus, Inc. Common Stock earnings per share and revenue
On Nov 04, 2026, EOLS reported earnings of -0.04 USD per share (EPS) for Q3 26, beating the estimate of -0.06 USD, resulting in a 36.71% surprise. Revenue reached 77.95 million, compared to an expected 79.22 million, with a -1.60% difference. The market reacted with a -9.04% price change (close before vs. close after earnings).
Looking ahead to Q4 26, -- analysts forecast an EPS of 0.06 USD, with revenue projected to reach 101.12 million USD, implying an decrease of -250.00% EPS, and increase of 29.72% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Omeros Corporation
Report Date
Nov 16, 2026 For Q3 26
Estimate
$0.03
Actual
$0.06
Surprise
+96.08%

Sanara MedTech Inc. Common Stock
Report Date
Nov 12, 2026 For Q3 26
Estimate
$0.06
Actual
-$0.16
Surprise
-361.44%

Oramed Pharmaceuticals Inc.
Report Date
Nov 12, 2026 For Q3 26
Estimate
$0.43
Actual
$0.43
Surprise
-1.96%

MacroGenics, Inc.
Report Date
Nov 12, 2026 For Q3 26
Estimate
-$0.06
Actual
-$0.32
Surprise
-367.15%

Glass House Brands Inc.
Report Date
Nov 16, 2026 For Q3 26
Estimate
-$0.04
Actual
-$0.14
Surprise
-191.06%

Immucell Corp
Report Date
Nov 12, 2026 For Q3 26
Estimate
-Actual
$0.10
Surprise
-

FitLife Brands, Inc. Common Stock
Report Date
Nov 16, 2026 For Q3 26
Estimate
$0.24
Actual
$0.16
Surprise
-34.64%

Rockwell Medical, Inc. (DE) Common Stock
Report Date
Nov 12, 2026 For Q3 26
Estimate
-$0.13
Actual
-$0.37
Surprise
-179.03%

Modular Medical, Inc. Common Stock
Report Date
Nov 16, 2026 For Q2 26
Estimate
-$0.10
Actual
-$0.90
Surprise
-782.35%

Cytosorbents Corp.
Report Date
Nov 12, 2026 For Q3 26
Estimate
-$0.91
Actual
-$0.57
Surprise
+36.82%
FAQ
What were Evolus, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2026?
For Q3 2026, Evolus, Inc. Common Stock reported EPS of -$0.04, beating estimates by 36.71%, and revenue of $77.95M, -1.6% below expectations.
How did the market react to Evolus, Inc. Common Stock's Q3 2026 earnings?
The stock price moved down -9.04%, changed from $7.47 before the earnings release to $6.79 the day after.
When is Evolus, Inc. Common Stock expected to report next?
The next earning report is scheduled for Mar 01, 2027.
What are the forecasts for Evolus, Inc. Common Stock's next earnings report?
Based on --
analysts, Evolus, Inc. Common Stock is expected to report EPS of $0.06 and revenue of $101.12M for Q4 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.